Archives for July 1, 2003

← 2003

Pfizer to sell Pharmacia diagnostics unit

Pfizer is considering the sale of its Pharmacia Diagnostics business, acquired alongside the rest of Pharmacia in a $60 billion deal that concluded in April.

Antibiotics R&D on the wane

The market for antibacterial drugs is becoming increasingly unattractive to major pharmaceutical companies, despite continued strong worldwide demand for these products and the growing threat of bacterial resistance, according to a report from...

Commission responds to G10 report

The European Commission has issued its long-awaited response to the G10 Medicines Report, intended as a blueprint for improving the European pharmaceutical industry's competitiveness while ensuring high levels of public health protection.

Panic offer seals ICN Bio deal

Former Yugoslav prime minister Milan Panic, who until recently had been at the helm of ICN Pharmaceuticals for 42 years, has bought the ICN Biomedicals division for $15 million.

Flexible fluid-handling range launched by Tecan

Switzerland's Tecan has introduced a range of laboratory automation workstations, under the Freedom EVO banner, which are designed to provide fluid handling applications in genomics, proteomics, drug discovery and clinical diagnostics.

Invitrogen to buy reagents company for $325m

Invitrogen has made a cash offer for fellow US company Molecular Probes in a deal which would give the firm a very strong presence in fluorescence reagents for use in labelling molecules for biological research and drug discovery.